PTC Therapeutics (NASDAQ:PTCT) Trading Down 2.9%

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) dropped 2.9% on Tuesday . The company traded as low as $38.61 and last traded at $39.10. Approximately 132,714 shares were traded during trading, a decline of 83% from the average daily volume of 801,563 shares. The stock had previously closed at $40.27. Analyst Ratings […]

Related Keywords

United States ,China ,Hong Kong ,America ,Allan Steven Jacobson ,Davidp Southwell ,Sg Americas Securities ,Therapeutics Inc ,Nasdaq ,China Universal Asset Management Co ,Goldman Sachs Group ,Lazard Asset Management ,Hong Kong Ltd ,Get Free Report ,Truist Financial ,Director Allan Steven Jacobson ,Director David ,Universal Asset Management ,Asset Management ,Kong Ltd ,Ptc Therapeutics ,Nasdaq Ptct ,Ptct ,Medical ,Stocks ,Technicals ,